open access
COVID-19 pneumonia detected by parathyroid scintigraphy
, 2
Affiliations- Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran
- Nuclear Medicine Department, Medical School, Shiraz University of Medical Science, Shiraz, Iran
open access
Abstract
We report a case of incidental diagnosis of COVID-19 pneumonia by parathyroid scintigraphy. A 53-year-old woman who had severe fatigue, and mild dyspnea underwent parathyroid scintigraphy due to increased serum parathyroid hormone (PTH) and serum calcium levels. Parathyroid scan was negative for abnormal parathyroid tissue. Although the patient had three negative results of COVID-19 PCR tests, significant 99m Tchexakis-2-methoxyisobutylisonitrile ([99mTc]MIBI) uptake is noticed in both lungs that was suspicious for Covid-19 pneumonia. The patient underwent CT scan of the chest for further evaluation. Diffuse groundglass opacities were identified in both lungs which were interpreted as typical feature for COVID-19 pneumonia.
Abstract
We report a case of incidental diagnosis of COVID-19 pneumonia by parathyroid scintigraphy. A 53-year-old woman who had severe fatigue, and mild dyspnea underwent parathyroid scintigraphy due to increased serum parathyroid hormone (PTH) and serum calcium levels. Parathyroid scan was negative for abnormal parathyroid tissue. Although the patient had three negative results of COVID-19 PCR tests, significant 99m Tchexakis-2-methoxyisobutylisonitrile ([99mTc]MIBI) uptake is noticed in both lungs that was suspicious for Covid-19 pneumonia. The patient underwent CT scan of the chest for further evaluation. Diffuse groundglass opacities were identified in both lungs which were interpreted as typical feature for COVID-19 pneumonia.
Keywords
COVID-19; [99mTc]MIBI; primary hyperparathyroidism
About this articleTitle
COVID-19 pneumonia detected by parathyroid scintigraphy
Journal
Issue
Article type
Clinical vignette
Pages
134-135
Published online
2022-07-11
Page views
4160
Article views/downloads
393
DOI
Pubmed
Bibliographic record
Nucl. Med. Rev 2022;25(2):134-135.
Keywords
COVID-19
[99mTc]MIBI
primary hyperparathyroidism
Authors
Mehrosadat Alavi
Yalda Moafpourian
References (8)- Madkhali T, Alhefdhi A, Chen H, et al. Primary hyperparathyroidism. Ulus Cerrahi Derg. 2016; 32(1): 58–66.
- Moralidis E. Radionuclide parathyroid imaging: a concise, updated review. Hell J Nucl Med. 2013; 16(2): 125–133.
- Jin YH, Cai L, Cheng ZS. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) . Mil Med Res. 2020; 7(1): 4.
- Xie X, Zhong Z, Zhao W, et al. Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR Testing. Radiology. 2020; 296(2): E41–E45.
- Caruso D, Polidori T, Guido G, et al. Typical and atypical COVID-19 computed tomography findings. World J Clin Cases. 2020; 8(15): 3177–3187.
- Stasiak CE, Cardoso FR, de Almeida SA, et al. Incidental finding of COVID-19 infection after [ 68Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancer . Eur J Nucl Med Mol Imaging. 2021; 48(2): 653–654.
- Malek H, Maghsudi M, Yaghoobi N. Extra-cardiac multifocal lung uptake of Tc-sestamibi in myocardial perfusion imaging: An asymptomatic case with coronavirus infection features. J Nucl Cardiol. 2020 [Epub ahead of print].
- Albano D, Bertagna F, Bertoli M, et al. Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region. J Nucl Med. 2020; 61(5): 632–636.
